Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 70.88% is 169% above its 5-year average of 26.38%, near the high end of its 5-year range (0.00%–100.00%).
11.76% below its 12-month average of 80.33%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 84.27%.
GROSS MARGIN
70.88%
GROSS MARGIN AVG TTM
80.33%
GROSS MARGIN AVG 3Y
42.61%
GROSS MARGIN AVG 5Y
26.38%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-11.76%
CURRENT VS 3Y AVG
+66.35%
CURRENT VS 5Y AVG
+168.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+72.02%
vs the sector median at left
Market Cap
$62.78M
Gross Margin
70.07%
TTM Avg
73.26%
3Y Avg
61.08%
5Y Avg
58.36%
Market Cap
$63.78M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
50.00%
5Y Avg
66.67%
Market Cap
$60.42M
Gross Margin
0.00%
TTM Avg
23.12%
3Y Avg
20.52%
5Y Avg
13.68%
Market Cap
$60.02M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | $62.62M | 70.88% | 80.33% | 42.61% | 26.38% |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | 70.07% | 73.26% | 61.08% | 58.36% |
| InterCure Ltd. (INCR)vs › | $63.02M | 14.40% | 12.47% | 23.60% | 30.84% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | 50.00% | 66.67% |
| Alps Group Inc (ALPS)vs › | $64.18M | 32.09% | 26.51% | 26.11% | 26.57% |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | 0.00% | 23.12% | 20.52% | 13.68% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| XBiotech Inc. (XBIT)vs › | $65.85M | 0.00% | 0.00% | 20.94% | 28.94% |
| Cingulate Inc. (CING)vs › | $65.86M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | 99.56% | 98.97% | 49.48% | 32.99% |
Gross Margin
70.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 84.27% |
| 2026-03-31 | 85.08% |
| 2025-12-31 | 88.24% |
| 2025-09-30 | 80.08% |
| 2025-06-30 | 63.98% |
| 2025-03-31 | 52.28% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
